Thank you for getting this message out to our brothers.
PROSTATE CANCER seminar at the Biltmore Hotel, 1200 Anastasia Ave, Coral Gables, FL., March 10th at 6:30 PM. Prostate Cancer Screening can save your life. As can early detection and if necessary, the appropriate treatment with the least amount of side effects. Here is an opportunity to speak personally with Dr. George Suarez, a Board Certified Urologist with over twenty years of experience, about the most common cancer in men. He will discuss all available prostate cancer treatments with emphasis on HIFU (High Intensity Focused Ultrasound) a procedure that is providing remarkable results with guys you know. Come and enjoy a relaxed atmosphere in which you can ask questions, listen to testimonials, and learn from others who may be experiencing the same issues as you. If you have any questions or would like to RSVP call or email Jim Bruce. If you cannot make it to the seminar but have questions please call.
Sincerely and best wishes,
Jim Bruce
brucejf1031@aol.com
Phone 305-773-1986
Wednesday, January 27, 2010
Tuesday, January 26, 2010
LATEST NEWS!!!!
HIFU Prostate Cancer Clinical Trial Now Enrolling (Houston)
--------------------------------------------------------------------------------
Date: 2010-01-25, 10:53AM CST
Reply to: comm-fysqv-1569636188@craigslist.org [Errors when replying to ads?]
--------------------------------------------------------------------------------
Looking for Options for your Prostate Cancer?
If you are one of the 40,000 men treated for prostate cancer with radiation only to have their cancer return, then this clinical trial may be of interest to you.
This study might be appropriate if you:
• Are between the age of 40 and 85
• Have organ confined (biopsy confirmed) recurrent prostate cancer (Clinical Stages T1c and T2a)
• Have been treated with EBRT (conventional, 3D conformal, or IMRT) two or more years prior
• Have not had any prior medical or surgical treatment for prostate cancer, other than EBRT or hormone therapy
• Meet other protocol specific inclusion criteria
The purpose of this clinical research study is to evaluate the effectiveness of a study device, Sonablate® 500, which uses High Intensity Focused Ultrasound, HIFU, for the treatment of subjects who have locally recurrent prostate cancer. The high intensity focused ultrasound (sound wave energy) acts to destroy diseased tissue in the prostate. This treatment is radiation-free and has fewer side effects than other cancer treatments including hormone therapy.
The procedure is minimally invasive and is performed in an outpatient setting. You will be seen in the clinic a total of up to 10 times over 1 year, to ensure the procedure has been successful.
For more information or to determine if you qualify for this research opportunity, please call toll-free 1-866-619-6026 or visit http://theprostatecancerstudy.com/cl.aspx
--------------------------------------------------------------------------------
Date: 2010-01-25, 10:53AM CST
Reply to: comm-fysqv-1569636188@craigslist.org [Errors when replying to ads?]
--------------------------------------------------------------------------------
Looking for Options for your Prostate Cancer?
If you are one of the 40,000 men treated for prostate cancer with radiation only to have their cancer return, then this clinical trial may be of interest to you.
This study might be appropriate if you:
• Are between the age of 40 and 85
• Have organ confined (biopsy confirmed) recurrent prostate cancer (Clinical Stages T1c and T2a)
• Have been treated with EBRT (conventional, 3D conformal, or IMRT) two or more years prior
• Have not had any prior medical or surgical treatment for prostate cancer, other than EBRT or hormone therapy
• Meet other protocol specific inclusion criteria
The purpose of this clinical research study is to evaluate the effectiveness of a study device, Sonablate® 500, which uses High Intensity Focused Ultrasound, HIFU, for the treatment of subjects who have locally recurrent prostate cancer. The high intensity focused ultrasound (sound wave energy) acts to destroy diseased tissue in the prostate. This treatment is radiation-free and has fewer side effects than other cancer treatments including hormone therapy.
The procedure is minimally invasive and is performed in an outpatient setting. You will be seen in the clinic a total of up to 10 times over 1 year, to ensure the procedure has been successful.
For more information or to determine if you qualify for this research opportunity, please call toll-free 1-866-619-6026 or visit http://theprostatecancerstudy.com/cl.aspx
HIFU SUCCESS DEPENDS ON THE SURGEON'S EXPERIENCE
About things I like
• Sat Jan 23 HIFU success depends by surgeon's experience
Researchers considered there have been many men who have had excellent outcomes after High Intensity Focused Ultrasound treatment , and they do not intend to leave the public with the idea that HIFU is a dangerous form of treatment. However, it is also very clear that it takes time and experience to learn to carry out HIFU well, and that, until that experience has been accumulated, clinicians may well not be able to achieve, with reliability, the quality of outcome that the patient is expecting. Even the clinicians using HIFU treatment in clinical trials in the USA today may have had limited training and limited experience with this technique, and potential patients are strongly advised to insist on a very detailed discussion of the individual physician’s experience before they commit to HIFU at this time.
• Sat Jan 23 HIFU success depends by surgeon's experience
Researchers considered there have been many men who have had excellent outcomes after High Intensity Focused Ultrasound treatment , and they do not intend to leave the public with the idea that HIFU is a dangerous form of treatment. However, it is also very clear that it takes time and experience to learn to carry out HIFU well, and that, until that experience has been accumulated, clinicians may well not be able to achieve, with reliability, the quality of outcome that the patient is expecting. Even the clinicians using HIFU treatment in clinical trials in the USA today may have had limited training and limited experience with this technique, and potential patients are strongly advised to insist on a very detailed discussion of the individual physician’s experience before they commit to HIFU at this time.
Friday, January 22, 2010
TESTIMONIAL
Patient Comments- Charles PDF | Print | E-mail
Patient Comments- Charles
"My name is Charles. I am the President and Founder of The Cancer Cure Coalition, a U.S. government approved non-profit foundation. The Foundation’s mission is to help cure and prevent cancer. Our website, www.cancercurecoalition.org, gives more information about our work.
We are especially interested in new and better treatments for cancer, particularly those that do less harm to the patient. On June 4, 2004, the Executive Director of my foundation and I visited with Dr. George Suarez at his office in Miami, Florida. Dr. Suarez is a board-certified urologist and he is the medical director of USHIFU, a company that markets equipment for high intensity focused ultrasound treatment.
We visited him to obtain information about the use of high intensity focused ultrasound for Prostate cancer patients. We learned that the treatment is in clinical trials in the United States and has already been approved in Mexico, the Dominican Republic, China, Japan, as well as leading countries in Europe.
We found Dr. Suarez to be a highly qualified urologist who has been using high intensity focused ultrasound (HIFU) for the treatment of prostate cancer patients for about a year. He told us he had successfully performed HIFU treatments on about 125 prostate cancer patients and that none of them had incontinency or impotence following treatment.
My Executive Director and I were both impressed by Dr. Suarez’s competency and we were excited about the potential of this new treatment for prostate cancer patients. Also for me personally, the information we obtained had a special importance.
I was diagnosed with advanced prostate cancer in the beginning of 2000. Initially I had success in controlling it using PC Spes, an herbal remedy, and a nutritional program. The details of my treatment are described on the Foundation website.
Recently my PSA started to rise, going over 20 and both my oncologist and urologist recommended I use hormonal castration possibly to be followed by cryoablation surgery. I was reluctant to do this because of the adverse side effects of these treatments and after learning about HIFU, I began to consider using it as an alternative.
About one week later, I visited Dr. Suarez again, this time with my wife and I asked him to take me as a patient. After a physical examination and a review of my records by Dr. Suarez, on his recommendation I decided to try the HIFU treatment.
It was done in the Dominican Republic on June 25th. There was no hospitalization and the treatment was done as an outpatient. The HIFU treatment itself took about two hours. I was awake during the procedure with anesthesia only from my waist down and I had no pain. After the procedure, I was taken back to the hotel and that evening I was able to get up for a dinner in my room.
The following day I toured the city of Santiago and the next day I flew back to New York City, carrying heavy bags. I wore a catheter for 12 days. My current side effects from the treatment are minimal bleeding in the urine. This is expected to stop in a few weeks as the remains of the cells from the prostate gland are expelled.
Although it is too early for me to report on the curative effects of the treatment, I can already say that I do not believe any other invasive treatment has the minimal side effects of HIFU. Certainly surgery, radiation and chemical or surgical castration are more harmful in their side effects on the patients.
It is my hope that HIFU will be approved in the United States as it has been elsewhere, and that it will be of benefit to many prostate cancer patients. There is even the possibility of this treatment being used for other cancers such as breast, liver and kidney, as is already being done in China.
Charles
Patient Comments- Charles
"My name is Charles. I am the President and Founder of The Cancer Cure Coalition, a U.S. government approved non-profit foundation. The Foundation’s mission is to help cure and prevent cancer. Our website, www.cancercurecoalition.org, gives more information about our work.
We are especially interested in new and better treatments for cancer, particularly those that do less harm to the patient. On June 4, 2004, the Executive Director of my foundation and I visited with Dr. George Suarez at his office in Miami, Florida. Dr. Suarez is a board-certified urologist and he is the medical director of USHIFU, a company that markets equipment for high intensity focused ultrasound treatment.
We visited him to obtain information about the use of high intensity focused ultrasound for Prostate cancer patients. We learned that the treatment is in clinical trials in the United States and has already been approved in Mexico, the Dominican Republic, China, Japan, as well as leading countries in Europe.
We found Dr. Suarez to be a highly qualified urologist who has been using high intensity focused ultrasound (HIFU) for the treatment of prostate cancer patients for about a year. He told us he had successfully performed HIFU treatments on about 125 prostate cancer patients and that none of them had incontinency or impotence following treatment.
My Executive Director and I were both impressed by Dr. Suarez’s competency and we were excited about the potential of this new treatment for prostate cancer patients. Also for me personally, the information we obtained had a special importance.
I was diagnosed with advanced prostate cancer in the beginning of 2000. Initially I had success in controlling it using PC Spes, an herbal remedy, and a nutritional program. The details of my treatment are described on the Foundation website.
Recently my PSA started to rise, going over 20 and both my oncologist and urologist recommended I use hormonal castration possibly to be followed by cryoablation surgery. I was reluctant to do this because of the adverse side effects of these treatments and after learning about HIFU, I began to consider using it as an alternative.
About one week later, I visited Dr. Suarez again, this time with my wife and I asked him to take me as a patient. After a physical examination and a review of my records by Dr. Suarez, on his recommendation I decided to try the HIFU treatment.
It was done in the Dominican Republic on June 25th. There was no hospitalization and the treatment was done as an outpatient. The HIFU treatment itself took about two hours. I was awake during the procedure with anesthesia only from my waist down and I had no pain. After the procedure, I was taken back to the hotel and that evening I was able to get up for a dinner in my room.
The following day I toured the city of Santiago and the next day I flew back to New York City, carrying heavy bags. I wore a catheter for 12 days. My current side effects from the treatment are minimal bleeding in the urine. This is expected to stop in a few weeks as the remains of the cells from the prostate gland are expelled.
Although it is too early for me to report on the curative effects of the treatment, I can already say that I do not believe any other invasive treatment has the minimal side effects of HIFU. Certainly surgery, radiation and chemical or surgical castration are more harmful in their side effects on the patients.
It is my hope that HIFU will be approved in the United States as it has been elsewhere, and that it will be of benefit to many prostate cancer patients. There is even the possibility of this treatment being used for other cancers such as breast, liver and kidney, as is already being done in China.
Charles
LOOKING FOR OPTIONS ON PROSTATE CANCER?
Looking for Options for your Prostate Cancer?
If you are one of the 40,000 men treated for prostate cancer with
radiation only to have their cancer return, then this clinical trial
may be of interest to you.
This study might be appropriate if you:
• Are between the age of 40 and 85
• Have organ confined (biopsy confirmed) recurrent prostate cancer
(Clinical Stages T1c and T2a)
• Have been treated with EBRT (conventional, 3D conformal, or IMRT)
two or more years prior
• Have not had any prior medical or surgical treatment for prostate
cancer, other than EBRT or hormone therapy
• Meet other protocol specific inclusion criteria
The purpose of this clinical research study is to evaluate the
effectiveness of a study device, Sonablate® 500, which uses High
Intensity Focused Ultrasound, HIFU, for the treatment of subjects who
have locally recurrent prostate cancer. The high intensity focused
ultrasound (sound wave energy) acts to destroy diseased tissue in the
prostate. This treatment is radiation-free and has fewer side effects
than other cancer treatments including hormone therapy.
The procedure is minimally invasive and is performed in an outpatient
setting. You will be seen in the clinic a total of up to 10 times
over 1 year, to ensure the procedure has been successful.
For more information or to determine if you qualify for this research
opportunity, please call toll-free 1-866-619-6026 or visit
www.theprostatecancerstudy.com/go.aspx
If you are one of the 40,000 men treated for prostate cancer with
radiation only to have their cancer return, then this clinical trial
may be of interest to you.
This study might be appropriate if you:
• Are between the age of 40 and 85
• Have organ confined (biopsy confirmed) recurrent prostate cancer
(Clinical Stages T1c and T2a)
• Have been treated with EBRT (conventional, 3D conformal, or IMRT)
two or more years prior
• Have not had any prior medical or surgical treatment for prostate
cancer, other than EBRT or hormone therapy
• Meet other protocol specific inclusion criteria
The purpose of this clinical research study is to evaluate the
effectiveness of a study device, Sonablate® 500, which uses High
Intensity Focused Ultrasound, HIFU, for the treatment of subjects who
have locally recurrent prostate cancer. The high intensity focused
ultrasound (sound wave energy) acts to destroy diseased tissue in the
prostate. This treatment is radiation-free and has fewer side effects
than other cancer treatments including hormone therapy.
The procedure is minimally invasive and is performed in an outpatient
setting. You will be seen in the clinic a total of up to 10 times
over 1 year, to ensure the procedure has been successful.
For more information or to determine if you qualify for this research
opportunity, please call toll-free 1-866-619-6026 or visit
www.theprostatecancerstudy.com/go.aspx
Thursday, January 21, 2010
GEORGE M. SUAREZ, M.D. forwarded this interesting article:
Wednesday, 20 January 2010
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Via Conca 71, I-60-126 Torrette, Ancona, Italy.
Focal therapy of the prostate is defined as prostate gland ablation aiming at eradication of unifocal low-risk prostate cancer, and preserving uninvolved (peri-) prostatic tissue and therefore quality of life. The major arguments against focal therapy can be classified under the headings of understaging and multifocality. The argument of understaging highlights the importance of the occasional, but troublesome, finding of a large, extraprostatic or high-grade tumor (Gleason score > or = 7) in about a quarter of radical prostatectomy specimens removed from men initially classified as having a low-risk tumor. Indeed, 85% of all prostate cancer cases are multifocal. These concerns can be offset by additional testing: another biopsy, especially a transperineal mapping biopsy, and magnetic resonance imaging (MRI) of the prostate. The technology needed to ablate small regions or sectors of the prostate harboring a known cancer is rapidly becoming available. Cryotherapy is already being used and the preliminary data are encouraging, Ultrasound-guided high-intensity focused ultrasound (HIFU), photodynamic therapy using newly developed light-sensitizing agents, and MRI-guided HIFU are all promising new tools.
Written by:
Mazzucchelli R, Scarpelli M, Cheng L, Lopez-Beltran A, Galosi AB, Kirkali Z, Montironi R. Are you the author?
Reference:
Anticancer Res. 2009 Dec;29(12):5155-61.
PubMed Abstract
PMID:20044631
UroToday.com Prostate Cancer Section
Wednesday, 20 January 2010
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Via Conca 71, I-60-126 Torrette, Ancona, Italy.
Focal therapy of the prostate is defined as prostate gland ablation aiming at eradication of unifocal low-risk prostate cancer, and preserving uninvolved (peri-) prostatic tissue and therefore quality of life. The major arguments against focal therapy can be classified under the headings of understaging and multifocality. The argument of understaging highlights the importance of the occasional, but troublesome, finding of a large, extraprostatic or high-grade tumor (Gleason score > or = 7) in about a quarter of radical prostatectomy specimens removed from men initially classified as having a low-risk tumor. Indeed, 85% of all prostate cancer cases are multifocal. These concerns can be offset by additional testing: another biopsy, especially a transperineal mapping biopsy, and magnetic resonance imaging (MRI) of the prostate. The technology needed to ablate small regions or sectors of the prostate harboring a known cancer is rapidly becoming available. Cryotherapy is already being used and the preliminary data are encouraging, Ultrasound-guided high-intensity focused ultrasound (HIFU), photodynamic therapy using newly developed light-sensitizing agents, and MRI-guided HIFU are all promising new tools.
Written by:
Mazzucchelli R, Scarpelli M, Cheng L, Lopez-Beltran A, Galosi AB, Kirkali Z, Montironi R. Are you the author?
Reference:
Anticancer Res. 2009 Dec;29(12):5155-61.
PubMed Abstract
PMID:20044631
UroToday.com Prostate Cancer Section
Tuesday, January 19, 2010
Friday, January 15, 2010
SCHEDULE OF SEMINARS
WE INVITE YOU TO ATTEND ONE OF OUR PROSTATE CANCER TOWN HALL MEETINGS TO LEARN MORE ABOUT HIFU WITH DR. GEORGE SUAREZ, M.D. DURING THE FOLLOWING DATES:
TUESDAY, JANUARY 12 AT 6:30 P.M.
WEDNESDAY, MARCH 10 AT 6:30 P.M.
WEDNESDAY, MAY 12 AT 6:30 P.M.
WEDNESDAY, AUGUST 11,AT 6:30 P.M.
WEDNESDAY, OCTOBER 13, AT 6:30 P.M.
THESE SEMINARS ON PROSTATE CANCER ARE VERY INFORMATIVE. THERE IS NO COST TO THE GUESTS. YOU MAY ALSO HAVE A MINI CONSULTATION WITH DR. SUAREZ. ALL YOU NEED TO DO IS CALL 1 877 949-5325
BILTMORE HOTEL IN CORAL GABLES
TUTTLE ROOM
1200 ANASTASIA AVENUE
CORAL GABLES, FLORIDA 33134
TUESDAY, JANUARY 12 AT 6:30 P.M.
WEDNESDAY, MARCH 10 AT 6:30 P.M.
WEDNESDAY, MAY 12 AT 6:30 P.M.
WEDNESDAY, AUGUST 11,AT 6:30 P.M.
WEDNESDAY, OCTOBER 13, AT 6:30 P.M.
THESE SEMINARS ON PROSTATE CANCER ARE VERY INFORMATIVE. THERE IS NO COST TO THE GUESTS. YOU MAY ALSO HAVE A MINI CONSULTATION WITH DR. SUAREZ. ALL YOU NEED TO DO IS CALL 1 877 949-5325
BILTMORE HOTEL IN CORAL GABLES
TUTTLE ROOM
1200 ANASTASIA AVENUE
CORAL GABLES, FLORIDA 33134
Subscribe to:
Posts (Atom)